Sunday, 2 August 2020

DCGI gives nod to Serum Institute for phase 2 and 3 human clinical trials of Oxford's COVID-19 vaccine candidate

Currently, phase 2 and 3 clinical trials of Oxford's COVID-19 vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa.

from Moneycontrol https://ift.tt/3foFMdQ

No comments:

Post a Comment